Physician profile
Alexander M Solomon
NPI 1306372602
$1,086.54
in general payments reported to CMS, 2019-2025
21 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Neuro-Ophthalmology provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $142 · 2023: $384 · 2024: $148 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913 · Entertainment: $15.75 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.30 |
| Entertainment | $15.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $166.91 | 2023-2024 | Soliris, Ultomiris |
| Merz Pharmaceuticals, LLC | $135.03 | 2023-2025 | Xeomin |
| Ipsen Biopharmaceuticals, INC | $94.69 | 2022-2025 | Dysport |
| Horizon Therapeutics Plc | $91.10 | 2022-2023 | Tepezza |
| Argenx US, INC. | $74.55 | 2025 | Vyvgart Hytrulo |
| Springworks Therapeutics, INC. | $57.99 | 2025 | Gomekli |
| Ge Healthcare | $52.26 | 2023 | |
| Kyowa Kirin, INC. | $50.66 | 2022-2024 | Nourianz |
| Mdd US Operations, LLC | $47.82 | 2025 | |
| Acadia Pharmaceuticals INC | $45.55 | 2025 | Nuplazid, Daybue |
| Abbvie INC. | $38.99 | 2024-2025 | |
| Dompe US, INC. | $33.12 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.51 | 2024 | |
| Caris Mpi, INC. | $28.33 | 2025 | Mi Cancer Seek |
| Bausch & Lomb Americas INC. | $21.81 | 2025 | Miebo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $21.23 | 2023 | Optune |
| Amgen INC. | $20.20 | 2024 | Uplizna |
| Abbott Laboratories | $20.12 | 2025 | Infinity |
| Microtransponder, INC. | $19.78 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.14 | 2024 | |
| Optos, INC. | $15.75 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.